Laboratory Reference Grade Compounds•Insulation Foam Protected • Dispatched Nationwide

Dispatched from Metro Manila · J&T Express•Instant GCash, Maya & Bank QR

1 / 9

Metabolic & Weight Management Peptides

Cotadutide (10mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard

Protocol SOP↓

₱3,200.00

Out of stock

Net Content10MG

InclusionVial Only

Volume Discounts:Up to 20% OFF

SOPReconstitution Telemetry (10MG)

Diluent:mL

Concentration10.00 mg/mLin 1.0mL BAC

Standard Dose300 mcg – 600 mcg Daily SubQSyringe: 6.0 units (0.06 mL)

Scale (1 Unit)100 mcgper 0.01 mL (U-100)

• Lyophilized vial onlyMonograph SOP →

Cotadutide (10mg Research Vial)10MG · Vial Only

₱3,200.00

Out of stock

Net Content10MG

InclusionVial Only

Volume Discounts:Up to 20% OFF

SOPReconstitution Telemetry (10MG)

Diluent:mL

Concentration10.00 mg/mLin 1.0mL BAC

Standard Dose300 mcg – 600 mcg Daily SubQSyringe: 6.0 units (0.06 mL)

Scale (1 Unit)100 mcgper 0.01 mL (U-100)

• Lyophilized vial onlyMonograph SOP →

Cotadutide (10mg Research Vial)10MG · Vial Only

₱3,200.00

Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: Cotadutide (MEDI0382) is a potent synthetic oxyntomodulin-like peptide engineered with balanced dual agonism at both GLP-1 and glucagon receptors, conjugated with a palmitoyl fatty acid chain for extended half-life.

How it works: By engaging both GLP-1R and GCGR, Cotadutide stimulates insulin release, delays gastric emptying, improves whole-body energy expenditure, and promotes renal hemodynamic preservation in models of diabetic nephropathy.

Why researchers study it: Studied in Phase 2 clinical trials for type 2 diabetes with chronic kidney disease (CKD) and non-alcoholic fatty liver disease.